3-[(S)-7-bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-propionic acid methyl ester
98%
- Product Code: 235174
CAS:
308242-23-1
| Molecular Weight: | 402.24 g./mol | Molecular Formula: | C₁₈H₁₆BrN₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry |
Product Description:
Used in the synthesis of benzodiazepine derivatives for research in central nervous system disorders. Acts as an intermediate in developing compounds with potential anxiolytic and anticonvulsant activity. Employed in medicinal chemistry to explore structure-activity relationships of GABA receptor modulators. Suitable for creating analogs in drug discovery programs targeting neurological and psychiatric conditions.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 250mg | 10-20 days | €12.91 |
+
-
|
| 1g | 10-20 days | €15.81 |
+
-
|
| 5g | 10-20 days | €66.67 |
+
-
|
| 25g | 10-20 days | €296.47 |
+
-
|
3-[(S)-7-bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-propionic acid methyl ester
Used in the synthesis of benzodiazepine derivatives for research in central nervous system disorders. Acts as an intermediate in developing compounds with potential anxiolytic and anticonvulsant activity. Employed in medicinal chemistry to explore structure-activity relationships of GABA receptor modulators. Suitable for creating analogs in drug discovery programs targeting neurological and psychiatric conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :